About InsuLife®

InsuLife is a Norwegian company aiming at developing and bringing the unparalleled investigational INS-2301 skin-applied insulin to market. This includes the carrying out of any and all necessary product studies and authorization activities.

INS-2301 will represent an international innovation and paradigm shift. Skin-applied Insulin has the potential to fulfill a need for people with diabetes who want to avoid needles and to take insulin in the most practical way.

There is no transdermal insulin in the global pharmaceutical market today. InsuLife are developing a novel form of apply-on-the-skin insulin. Efficacy is expected to be comparable to the traditional subcutaneous injections.

We want to improve everyday life for people with diabetes by providing access to transdermal insulin and other diabetes medicines.
Our mission is to provide diabetics with convenient, painless and affordable Insulin.
Our Core Values

Selfless Drive

We seek passionate collaborators, people who are dedicated to improving the health and happiness of the world.

Courageous Hearts

We seek compassionate people who make the workplace a training ground for personal growth and transformation.

Curious Minds

We seek explorers, people who are willing to go to new places and are open to testing, learning and iterating as they go.
Subscribe for InsuLife News Updates
Sign up to receive the latest InsuLife news, updates and investing information delivered right to your inbox.
Newsletter Form (#1)
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved